enow.com Web Search

  1. Ads

    related to: monoclonal antibody for migraines symptoms dizziness

Search results

  1. Results from the WOW.Com Content Network
  2. Antimigraine drug - Wikipedia

    en.wikipedia.org/wiki/Antimigraine_drug

    Erenumab is a highly selective human monoclonal antibody which is a promising new development in migraine treatment. [14] It has low risk of hepatoxicity like gepants can have, due to being mostly eliminated via proteolysis.

  3. Eptinezumab - Wikipedia

    en.wikipedia.org/wiki/Eptinezumab

    Eptinezumab, sold under the brand name Vyepti, is a medication used for the preventive treatment of migraine in adults. [6] It is a monoclonal antibody that targets calcitonin gene-related peptides (CGRP) alpha and beta. [6] [8] It is administered by intravenous infusion. [6]

  4. Migraine-associated vertigo - Wikipedia

    en.wikipedia.org/wiki/Migraine-associated_vertigo

    Vertigo is a medically recognized term for the symptom of a vestibular system disturbance. It may include a feeling of rotation or illusory sensations of motion or both. The general term dizziness is used by nonmedical people for those symptoms but often refers to a feeling of light-headedness, giddiness, drowsiness, or faintness, all of which must be differentiated from true vertigo, [3 ...

  5. Erenumab - Wikipedia

    en.wikipedia.org/wiki/Erenumab

    The results were measured as mean monthly migraine days in months 4, 5, and 6. At baseline the patients experienced between 4 and 14 migraine days per month with an average of 8.3. The medication significantly reduced the number of migraine days per month by 3.2 in the 70-mg group and 3.7 in the 140-mg group, versus 1.8 in the placebo (0-mg) group.

  6. Guide to Migraines: 9 Different Types and Symptoms - AOL

    www.aol.com/news/guide-migraines-9-different...

    Vestibular migraine is when sufferers experience a combination of vertigo and dizziness with other migraine symptoms. Vertigo is when a person feels like the world around them is moving, and ...

  7. Galcanezumab - Wikipedia

    en.wikipedia.org/wiki/Galcanezumab

    Galcanezumab is a monoclonal antibody (a type of protein) designed to attach to and block CGRP, thereby helping blood vessels to return to their normal size. [3] This will stop the symptoms of migraine. [3] Galcanezumab is generally delivered through self-injections. [7] Common side effects include injection site reactions such as pain or redness.

  1. Ads

    related to: monoclonal antibody for migraines symptoms dizziness